YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Jubilant Pharmo
Jubilant Pharmo
BSE: 530019NSE: JUBLPHARMAISIN: INE700A01033

29th-Apr-2021 11:59Source: BSE

Jubilant Pharmova - Format of the Annual Disclosure to be made by an entity identified as a Large Corporate

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Compay Jubilant Pharmova Ltd
2 CIN L24116UP1978PLC004624
3 Report filed for FY 2021
Details of the borrowings (all figures in Rs crore)
4 Incremental borrowing done in FY(a) 100
5 Mandatory borrowing to be done through issuance of debt securities(b) = (25% of a) 25
6 Actual borrowings done through debt securities in FY(c) 100
7 Shortfall in the mandatory borrowing through debt securities, if any (d) = (b) - (c) { If the calculated value is zero or negative, write 'nil'} 0
8 Reasons for shortfall, if any, in mandatory borrowings through debt securities Not Applicable





Name of the Company Secretary :-Rajiv Shah
Designation :-Company Secretary and Compliance Officer
Name of the Chief Financial Officer :- Arun Kumar Sharma
Designation : -Chief Financial Officer

Date: 29/04/2021

Sections